PRESS RELEASE
FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
Greenwich Biosciences is the US leader in the field of cannabinoid prescription medicines.
OUR PROMISE
We’ve achieved this distinction because we made a promise to our patients and caregivers to look at things differently.
WHO WE ARE
It is our passion and purpose to continually seek solutions that transform the lives of those living with rare and severe neurological diseases.
MEDICAL INFORMATION
Access scientific and clinical information on Greenwich Biosciences products.
INQUIRIES
Healthcare professionals can find scientific and clinical information about Greenwich Biosciences products and submit medical inquiries for additional information.
PATIENTS & CAREGIVERS
"Our primary purpose is to make a positive and meaningful difference in the lives of patients and their caregivers."
– Justin Gover, Chief Executive Officer
FROM THE BEGINNING
Greenwich Biosciences puts patients at the center — and at the start.
Become part of a dynamic, cutting-edge pharmaceutical company on the forefront of therapeutic treatment.